95 related articles for article (PubMed ID: 16817232)
1. Functional analysis of CBP/p300 in embryonic orofacial mesenchymal cells.
Warner DR; Pisano MM; Greene RM
J Cell Biochem; 2006 Dec; 99(5):1374-9. PubMed ID: 16817232
[TBL] [Abstract][Full Text] [Related]
2. Cross-talk between the TGFbeta and Wnt signaling pathways in murine embryonic maxillary mesenchymal cells.
Warner DR; Greene RM; Pisano MM
FEBS Lett; 2005 Jul; 579(17):3539-46. PubMed ID: 15955531
[TBL] [Abstract][Full Text] [Related]
3. Intracellular dynamics of Smad-mediated TGFbeta signaling.
Greene RM; Nugent P; Mukhopadhyay P; Warner DR; Pisano MM
J Cell Physiol; 2003 Nov; 197(2):261-71. PubMed ID: 14502566
[TBL] [Abstract][Full Text] [Related]
4. Involvement of {beta}-catenin and unusual behavior of CBP and p300 in glucocorticosteroid signaling in Schwann cells.
Fonte C; Grenier J; Trousson A; Chauchereau A; Lahuna O; Baulieu EE; Schumacher M; Massaad C
Proc Natl Acad Sci U S A; 2005 Oct; 102(40):14260-5. PubMed ID: 16186500
[TBL] [Abstract][Full Text] [Related]
5. Fibroblast expression of the coactivator p300 governs the intensity of profibrotic response to transforming growth factor beta.
Bhattacharyya S; Ghosh AK; Pannu J; Mori Y; Takagawa S; Chen G; Trojanowska M; Gilliam AC; Varga J
Arthritis Rheum; 2005 Apr; 52(4):1248-58. PubMed ID: 15818659
[TBL] [Abstract][Full Text] [Related]
6. The steroid receptor co-activator-1 (SRC-1) potentiates TGF-beta/Smad signaling: role of p300/CBP.
Dennler S; Pendaries V; Tacheau C; Costas MA; Mauviel A; Verrecchia F
Oncogene; 2005 Mar; 24(11):1936-45. PubMed ID: 15688032
[TBL] [Abstract][Full Text] [Related]
7. Cited2 modulates TGF-beta-mediated upregulation of MMP9.
Chou YT; Wang H; Chen Y; Danielpour D; Yang YC
Oncogene; 2006 Sep; 25(40):5547-60. PubMed ID: 16619037
[TBL] [Abstract][Full Text] [Related]
8. Functional interaction between Smad, CREB binding protein, and p68 RNA helicase.
Warner DR; Bhattacherjee V; Yin X; Singh S; Mukhopadhyay P; Pisano MM; Greene RM
Biochem Biophys Res Commun; 2004 Nov; 324(1):70-6. PubMed ID: 15464984
[TBL] [Abstract][Full Text] [Related]
9. Transcriptional coactivator p300 regulates glucose-induced gene expression in endothelial cells.
Chen S; Feng B; George B; Chakrabarti R; Chen M; Chakrabarti S
Am J Physiol Endocrinol Metab; 2010 Jan; 298(1):E127-37. PubMed ID: 19903865
[TBL] [Abstract][Full Text] [Related]
10. Novel interaction between nuclear co-activator CBP and the CDK5 activator binding protein - C53.
Yin X; Warner DR; Roberts EA; Pisano MM; Greene RM
Int J Mol Med; 2005 Aug; 16(2):251-6. PubMed ID: 16012757
[TBL] [Abstract][Full Text] [Related]
11. The ability of E1A to rescue ras-induced premature senescence and confer transformation relies on inactivation of both p300/CBP and Rb family proteins.
Deng Q; Li Y; Tedesco D; Liao R; Fuhrmann G; Sun P
Cancer Res; 2005 Sep; 65(18):8298-307. PubMed ID: 16166306
[TBL] [Abstract][Full Text] [Related]
12. Schistosoma mansoni CBP/p300 has a conserved domain structure and interacts functionally with the nuclear receptor SmFtz-F1.
Bertin B; Oger F; Cornette J; Caby S; Noël C; Capron M; Fantappie MR; Rumjanek FD; Pierce RJ
Mol Biochem Parasitol; 2006 Apr; 146(2):180-91. PubMed ID: 16427147
[TBL] [Abstract][Full Text] [Related]
13. Role of plant CBP/p300-like genes in the regulation of flowering time.
Han SK; Song JD; Noh YS; Noh B
Plant J; 2007 Jan; 49(1):103-14. PubMed ID: 17144897
[TBL] [Abstract][Full Text] [Related]
14. The tumor suppressor KLF11 mediates a novel mechanism in transforming growth factor beta-induced growth inhibition that is inactivated in pancreatic cancer.
Buck A; Buchholz M; Wagner M; Adler G; Gress T; Ellenrieder V
Mol Cancer Res; 2006 Nov; 4(11):861-72. PubMed ID: 17114344
[TBL] [Abstract][Full Text] [Related]
15. Sustained TGF beta exposure suppresses Smad and non-Smad signalling in mammary epithelial cells, leading to EMT and inhibition of growth arrest and apoptosis.
Gal A; Sjöblom T; Fedorova L; Imreh S; Beug H; Moustakas A
Oncogene; 2008 Feb; 27(9):1218-30. PubMed ID: 17724470
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of the acetyltransferases p300 and CBP reveals a targetable function for p300 in the survival and invasion pathways of prostate cancer cell lines.
Santer FR; Höschele PP; Oh SJ; Erb HH; Bouchal J; Cavarretta IT; Parson W; Meyers DJ; Cole PA; Culig Z
Mol Cancer Ther; 2011 Sep; 10(9):1644-55. PubMed ID: 21709130
[TBL] [Abstract][Full Text] [Related]
17. Improvement of sensitivity to platinum compound with siRNA knockdown of upregulated genes in platinum complex-resistant ovarian cancer cells in vitro.
Yanagie H; Hisa T; Ogata A; Miyazaki A; Nonaka Y; Nishihira T; Osada I; Sairennji T; Sugiyama H; Furuya Y; Kidani Y; Takamoto S; Takahashi H; Eriguchi M
Biomed Pharmacother; 2009 Sep; 63(8):553-60. PubMed ID: 18571892
[TBL] [Abstract][Full Text] [Related]
18. Myostatin induces p300 degradation to silence cyclin D1 expression through the PI3K/PTEN/Akt pathway.
Ji M; Zhang Q; Ye J; Wang X; Yang W; Zhu D
Cell Signal; 2008 Aug; 20(8):1452-8. PubMed ID: 18472397
[TBL] [Abstract][Full Text] [Related]
19. Sprouty2 downregulation plays a pivotal role in mediating crosstalk between TGF-beta1 signaling and EGF as well as FGF receptor tyrosine kinase-ERK pathways in mesenchymal cells.
Ding W; Shi W; Bellusci S; Groffen J; Heisterkamp N; Minoo P; Warburton D
J Cell Physiol; 2007 Sep; 212(3):796-806. PubMed ID: 17516543
[TBL] [Abstract][Full Text] [Related]
20. Müllerian inhibiting substance regulates its receptor/SMAD signaling and causes mesenchymal transition of the coelomic epithelial cells early in Müllerian duct regression.
Zhan Y; Fujino A; MacLaughlin DT; Manganaro TF; Szotek PP; Arango NA; Teixeira J; Donahoe PK
Development; 2006 Jun; 133(12):2359-69. PubMed ID: 16687449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
